Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaoxin Hu

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Materials (Basel, Switzerland)|February 11, 2023
Thermal Regulation Performance of Shape-Stabilized-Phase-Change-Material-Based Prefabricated Wall for Green Grain StorageChangnv Zeng, Chaoxin Hu, Wanwan Li
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 14, 2014
Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agentsVenugopal Chenna, Chaoxin Hu, Saeed R Khan
Current Drug Targets|March 20, 2010
Targeting cellular proapoptotic molecules for developing anticancer agents from marine sourcesXiukun Lin, Ming Liu, Chaoxin Hu, et al.
Biochemical and Biophysical Research Communications|December 17, 2013
Imaging Axl expression in pancreatic and prostate cancer xenograftsSridhar Nimmagadda, Mrudula Pullambhatla, Ala Lisok, et al.
Cancer Biology & Therapy|April 12, 2007
A novel polypeptide from shark cartilage with potent anti-angiogenic activityLanhong Zheng, Peixue Ling, Zheng Wang, et al.
Molecular Cancer Therapeutics|September 19, 2007
Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domainYuxin Qin, Linghua Meng, Chaoxin Hu, et al.
Molecular Cancer Therapeutics|March 6, 2012
Inhibition of OCTN2-mediated transport of carnitine by etoposideChaoxin Hu, Cynthia S Lancaster, Zhili Zuo, et al.
Molecular Cancer Therapeutics|May 2, 2015
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft ModelsChaoxin Hu, Tikva Dadon, Venugopal Chenna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidaseRyan M Franke, Ashley M Kosloske, Cynthia S Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1Mirte Mayke Streppel, Shweta Pai, Nathaniel R Campbell, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Materials (Basel, Switzerland)|February 11, 2023
Thermal Regulation Performance of Shape-Stabilized-Phase-Change-Material-Based Prefabricated Wall for Green Grain StorageChangnv Zeng, Chaoxin Hu, Wanwan Li
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 14, 2014
Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agentsVenugopal Chenna, Chaoxin Hu, Saeed R Khan
Current Drug Targets|March 20, 2010
Targeting cellular proapoptotic molecules for developing anticancer agents from marine sourcesXiukun Lin, Ming Liu, Chaoxin Hu, et al.
Biochemical and Biophysical Research Communications|December 17, 2013
Imaging Axl expression in pancreatic and prostate cancer xenograftsSridhar Nimmagadda, Mrudula Pullambhatla, Ala Lisok, et al.
Cancer Biology & Therapy|April 12, 2007
A novel polypeptide from shark cartilage with potent anti-angiogenic activityLanhong Zheng, Peixue Ling, Zheng Wang, et al.
Molecular Cancer Therapeutics|September 19, 2007
Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domainYuxin Qin, Linghua Meng, Chaoxin Hu, et al.
Molecular Cancer Therapeutics|March 6, 2012
Inhibition of OCTN2-mediated transport of carnitine by etoposideChaoxin Hu, Cynthia S Lancaster, Zhili Zuo, et al.
Molecular Cancer Therapeutics|May 2, 2015
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft ModelsChaoxin Hu, Tikva Dadon, Venugopal Chenna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidaseRyan M Franke, Ashley M Kosloske, Cynthia S Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1Mirte Mayke Streppel, Shweta Pai, Nathaniel R Campbell, et al.
Pageof 2